First Reported Case of Pure Red Cell Aplasia Related to Sotorasib.

IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Internal Medicine Pub Date : 2025-04-01 Epub Date: 2024-09-04 DOI:10.2169/internalmedicine.3961-24
Katsuhiro Itogawa, Tatsuya Saito, Yuya Nakata, Hikari Amari, Hiroki Tahara, Nozomu Yoshino, Yuki Maeda, Motoko Nomura, Jun Shiihara, Yoshiaki Nagai, Hiromitsu Ohta, Yasuhiro Yamaguchi
{"title":"First Reported Case of Pure Red Cell Aplasia Related to Sotorasib.","authors":"Katsuhiro Itogawa, Tatsuya Saito, Yuya Nakata, Hikari Amari, Hiroki Tahara, Nozomu Yoshino, Yuki Maeda, Motoko Nomura, Jun Shiihara, Yoshiaki Nagai, Hiromitsu Ohta, Yasuhiro Yamaguchi","doi":"10.2169/internalmedicine.3961-24","DOIUrl":null,"url":null,"abstract":"<p><p>We herein report a 64-year-old man with KRAS<sup>G12C</sup>-mutated advanced lung adenocarcinoma previously treated with immune checkpoint inhibitors (ICIs). One month after starting second-line sotorasib treatment, the patient experienced a progressive decline in serum hemoglobin levels. Anemia was accompanied by markedly elevated serum erythropoietin levels and decreased reticulocyte levels. Bone marrow aspiration revealed pure red cell aplasia. No secondary causes other than medication use were identified. Suspected causative drugs were sotorasib and ICIs. Discontinuation of sotorasib for one week improved his anemia; therefore, the causative drug was identified as sotorasib.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"1089-1092"},"PeriodicalIF":1.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12021511/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2169/internalmedicine.3961-24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

We herein report a 64-year-old man with KRASG12C-mutated advanced lung adenocarcinoma previously treated with immune checkpoint inhibitors (ICIs). One month after starting second-line sotorasib treatment, the patient experienced a progressive decline in serum hemoglobin levels. Anemia was accompanied by markedly elevated serum erythropoietin levels and decreased reticulocyte levels. Bone marrow aspiration revealed pure red cell aplasia. No secondary causes other than medication use were identified. Suspected causative drugs were sotorasib and ICIs. Discontinuation of sotorasib for one week improved his anemia; therefore, the causative drug was identified as sotorasib.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
首例报告的与索托拉西布有关的纯红细胞增生症病例
我们在此报告了一名曾接受免疫检查点抑制剂(ICIs)治疗的 64 岁男性 KRASG12C 突变晚期肺腺癌患者。在开始索托拉西布二线治疗一个月后,患者的血清血红蛋白水平出现了进行性下降。贫血伴有血清促红细胞生成素水平明显升高和网织红细胞水平下降。骨髓穿刺显示纯红细胞再生不良。除用药外,未发现其他继发原因。疑似致病药物为索托拉西布和 ICIs。停用索托拉西布一周后,他的贫血症状有所改善;因此,确定致病药物为索托拉西布。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Internal Medicine
Internal Medicine 医学-医学:内科
CiteScore
1.90
自引率
8.30%
发文量
0
审稿时长
2.2 months
期刊介绍: Internal Medicine is an open-access online only journal published monthly by the Japanese Society of Internal Medicine. Articles must be prepared in accordance with "The Uniform Requirements for Manuscripts Submitted to Biomedical Journals (see Annals of Internal Medicine 108: 258-265, 1988), must be contributed solely to the Internal Medicine, and become the property of the Japanese Society of Internal Medicine. Statements contained therein are the responsibility of the author(s). The Society reserves copyright and renewal on all published material and such material may not be reproduced in any form without the written permission of the Society.
期刊最新文献
Recent Advances in Gastrointestinal Cancer Endoscopic Diagnosis and Treatment: Focusing on Older Adults. Development of Antiviral Drugs for Influenza. Acute Ischemic Stroke: Significance of Multimodal Pre-operative Prediction of Intracranial Atherosclerosis-related Large Vessel Occlusion. Recent Advances in Molecular Targeted Therapy for Inflammatory Bowel Disease. Development of New Molecularly Targeted Agents in Inflammatory Bowel Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1